Star Scientific (Nasdaq: STSI) and its wholly-owned subsidiary, Rock Creek Pharmaceuticals ("Rock Creek"), today reported on their continuing efforts to lessen the harm linked with tobacco use. Star Scientific, through its CEO Jonnie R. Williams, recently filed a new US Patent Application for a novel modification of its patented curing technology that results in the production of tobacco leaf that consistently contains levels of carcinogenic TSNAs (known as NNNs and NNKs) that are below detection even by the most sensitive measures. That patent application for zero-nitrosamine tobacco currently is pending before the US Patent and Trademark Office.
http://www.tobacco.org/news/282985.html
Imagine that. ZERO nitrosamine tobacco. Hopefully this process will be implemented by snus-manufacturers, so the FDA and other governments have even less ammo against the prohibition of snus. Even though the levels of TSNAs in snus are virtually harmless, this process could open the doors for the sale of snus worldwide.
The company that has patented this process in America is Star Scientific, the maker of Stonewall and Ariva tobacco pellets.
http://www.tobacco.org/news/282985.html
Imagine that. ZERO nitrosamine tobacco. Hopefully this process will be implemented by snus-manufacturers, so the FDA and other governments have even less ammo against the prohibition of snus. Even though the levels of TSNAs in snus are virtually harmless, this process could open the doors for the sale of snus worldwide.
The company that has patented this process in America is Star Scientific, the maker of Stonewall and Ariva tobacco pellets.
Comment